Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Acadesine

EU orphan designation number: EU/3/05/280   
Active ingredient: Acadesine
Indication: Treatment of B-cell chronic lymphocytic leukemia (B-CLL)
Sponsor: Advancell - Advanced In Vitro Cell Technologies S.A.
Via Augusta 59, 3rd floor, door 313, 08006 Barcelona, España

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/05/2005 Orphan designation EMEA/OD/010/05 (2005)1659 of 27/05/2005
19/09/2008 Change of name and/or address of sponsor
05/07/2013 Change of name and/or address of sponsor